Close

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more

Shire news

17 Apr 2014 First quarter 2014 results date notification - May 1, 2014
15 Apr 2014 Pre-quarterly Results Communication
01 Apr 2014 Director/PDMR Share Dealings
01 Apr 2014 Total Voting Rights
31 Mar 2014 Director/PDMR Share Dealings
27 Mar 2014 Shire submits INTUNIV® (guanfacine extended release) Marketing Authorisation Application to EMA
27 Mar 2014 2013 Annual Report - DTR 6.3.5 Disclosure
14 Mar 2014 Director Declaration
14 Mar 2014 Shire Pharmaceuticals Initiates Voluntary Nationwide Recall Of One Batch, Packaged into Three Lots, of VPRIV® (velaglucerase alfa for injection)
07 Mar 2014 Director/PDMR Shareholding
06 Mar 2014 Director/PDMR Shareholding
04 Mar 2014 Shire to present at the Cowen and Company 34th Annual Health Care Conference
03 Mar 2014 Elections for Interim Dividend in Respect of the Six Months to December 31, 2013
03 Mar 2014 Director/PDMR Shareholding
03 Mar 2014 Total Voting Rights
28 Feb 2014 Shire Recognizes Rare Disease Day 2014
25 Feb 2014 ViroPharma announces results of tender offer for its 2.00% Convertible Senior Notes Due 2017 (49KB PDF)
25 Feb 2014 STATEMENT RELATING TO SHIRE’S VPRIV® (VELAGLUCERASE ALFA FOR INJECTION) PRESS RELEASE DATED JUNE 28, 2012
21 Feb 2014 Director’s Share Dealings
20 Feb 2014 Director's Share Dealings
17 Feb 2014 Director's Share Dealings
13 Feb 2014 Chief Financial Officer Graham Hetherington to step down
13 Feb 2014 Shire delivers double digit product sales growth and 23% increase in Non GAAP earnings per ADS
06 Feb 2014 Shire Reports Top-line Results from Two Phase 3 Studies for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) as an Adjunctive Treatment for Adults with Major Depressive Disorder
04 Feb 2014 Historical income statements recast for DERMAGRAFT discontinued operations
03 Feb 2014 Total Voting Rights
30 Jan 2014 Full Year 2013 results date notification – February 13, 2014
24 Jan 2014 ViroPharma announces tender offer for its 2.00% Convertible Senior Notes Due 2017 (57KB PDF)
24 Jan 2014 Shire successfully completes tender offer for ViroPharma
23 Jan 2014 Susan Kilsby to succeed Matthew Emmens as Chairman of Shire
17 Jan 2014 Cancellation of listing and admission to trading of Shire plc Convertible Bonds due 2014
17 Jan 2014 Shire Executes Agreement to Divest DERMAGRAFT®
15 Jan 2014 Shire waives OFT condition relating to the acquisition of ViroPharma Inc.
14 Jan 2014 Guidance Update
10 Jan 2014 Shire extends tender offer for ViroPharma
02 Jan 2014 Total Voting Rights

Did you know...

You can sign up to receive email and SMS alerts so that you can keep up to speed with our latest news.

Email and SMS alerts

Did you know...

We donated over $35,000 in
outdated laboratory
equipment
to local
schools?